CTRI/2021/08/035549
Completed
Phase 3
Clinical evaluation and therapeutic management of Baalavatham(paresis) by maha analuruva chooranam (internal) along with Chennagarapattai ennai (external)in children - Clinical study
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: G328- Other specified degenerative disorders of nervous system in diseases classified elsewhere
- Sponsor
- ational Institute of Siddha
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Monoparesis
- •Tetraparesis
- •Quadriparesis
- •Cerebral palsy
- •Difficulty in use against gravity of both upper and lower limbs
- •Inability and disability of both upper and lower limbs
- •Loss of power and tone in the muscle
Exclusion Criteria
- •Severe aggressive with ADHD
- •Congenital heart disease
- •Any other serious illness
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
thaamani Nei(Internal) and Nellikkai thylam (External) in the management of Mantha Sanni (Autism spectrum disorder)CTRI/2021/08/035524ational Institute of Siddha
Not yet recruiting
Phase 2
STUDY ON SIDDHA MEDICINE TO MANAGE AND TREAT MENTAL AND BEHAVIOURAL PROBLEMS IN CHILDREHealth Condition 1: F01-F99- Mental, Behavioral and Neurodevelopmental disordersCTRI/2019/12/022286ational Institute of Siddha
Not yet recruiting
Phase 2
Clinical management of maantha sanni(Autism spectrum disorder)with maantha sanni thylam(Internal&External)Health Condition 1: null- 1 Poor eye contact 2 Mild aggresive behavior 3 Repetative behavior 4 Lack of communication skillsCTRI/2018/08/015287ATIONAL INSTITUTE OF SIDDHA
Recruiting
Not Applicable
Investigation of clinical course and treatment of acute exacerbation of interstitial lung disease - A Prospective Observational StudyJPRN-UMIN000043154Hamamatsu University School of Medicine400
Recruiting
Phase 1
Corneal injury treatment protocol using 50% Autologous Serum Eye DropsRBR-34d3jv2niversidade Federal de São Paulo - UNIFESP/EPM